2019 was an inflection point for Femtech, a healthtech category estimated by F&S to become a $50 billion dollar industry by year 2025. In the past 12 months, Femtech received just short of $800 million in funding. Women in leading positions at investment firms are increasingly vouching for founders addressing problems that disproportionately affect women and been insufficiently researched, or categories where there’s opportunities for better designed products and services. They are excited to see more exits this year, a clearer path to creating successful solutions with high impact, and a well-oiled funding ecosystem. Heart disease, fertility treatment outcomes, pain management solutions… These are some of the trends and opportunities that these 3 investors expect to see in Femtech in 2020.
Read the full article: Femtech in 2020: Investors Share Trends and Opportunities in Women’s Health Technology //